Overexpressed LDHA is associated with poor prognosis in many tumors, including NSCLC, breast cancer, gallbladder carcinoma, and gastrointestinal cancer (Mizuno et al., 2020; Guddeti et al., 2019). The gene discussed is LDHA; the disease is non-small cell lung carcinoma.